Skyrocketing Pharmaceutical Imports to the U.S. Endanger National Security
U.S. pharmaceutical imports have skyrocketed in the last ten years, with imports from China, India and Mexico leading the surge.
Department of Energy Official Calls For More U.S.-Based Solar Equipment Production
A Department of Energy official warns that China’s outsized role in the solar industry is a headwind for Biden’s green energy plans, and energy security.
November Trade Deficit Falls 21% to $61.5 Billion, But $1 Trillion-Plus Deficit Record Beat
The November trade deficit fell, but that didn’t stop the U.S. from record imports this year. The goods deficit is now over $1.1 trillion.
China Investment Risks Seen Rising in 2023. Some States Banning Chinese Stocks
Will China’s risk profile improve this year? By the looks of things, it will not. Some governments are divesting. For government fiduciaries, is it prudent to invest retirement accounts in China?
Should Amazon, Other Online Retailers, Let Consumers Finally Know Where Their Products Come From in 2023?
Online retailers don’t have to post where their products are made. Country of Origin labeling online would help people find US alternatives to imports.
World Cup Soccer as a Model for a Deglobalized World
There is a growing consensus in the U.S. and many other advanced economies that we must move away from globalization, and towards more localized economies,
Senate Hearing Bemoans Worker Shortages, Wonders If Reshoring Can Work
A Senate Commerce subcommittee hearing heard from witnesses who said worker shortages will ultimately be a drag on U.S. reshoring efforts. Pharmaceutical reps warned of high energy costs, which could add to import dependence.
Ambassador Bob Lighthizer Tells Laura Ingraham Why the GOP Must Embrace Tariffs and Balanced Trade
Ambassador Bob Lighthizer, the former U.S. Trade Representative in the Trump administration, joined Laura Ingraham on Fox News Channel to discuss trade, the TPP, and
India Drug Maker Aurobindo Keeps Getting Poor Grades by the FDA
One of India’s pharmaceutical labs has run afoul of the FDA many times this year. The U.S. is dependent on foreign labs like Aurobindo for its drug supply. Can the government help change that?
As 2022 Draws to a Close, Globalization is Still Against the Ropes
As 2022 winds down, one thing remains clear, globalization is losing support among policy makers, and even among influencers like Paul Krugman.
